Loading clinical trials...
Loading clinical trials...
The objectives of this study are: (1) to evaluate the safety and tolerability of VP 20621 dosed orally for up to 14 days in adults previously treated for CDI; (2) to characterize the frequency and dur...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Shire
NCT06237452 · Clostridium Difficile, Clostridium Difficile Infections, and more
NCT03325855 · Fecal Microbiota Transplantation, Clostridium Difficile Infection, and more
NCT01905709 · Clostridium Difficile Infection
NCT04014413 · Crohn Disease, Ulcerative Colitis, and more
NCT05831189 · Clostridium Difficile Infection Recurrence
Modesto, California
Palm Desert, California
Sacramento, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions